国产抗体筛选红细胞试剂在青海高原多民族地区适宜性评估  

Evaluation of the adaptability of Chinese made antibody RBC screening reagents in the multi-race region of Qinghai plateau

作　　者：杨尖措[1] 仲海娟[1] 赵铁民[1] 邹敏 周华友[2] 

机构地区：[1]青海红十字医院输血科,青海西宁810000 [2]南方医科大学南方医院输血科

出　　处：《中国输血杂志》2017年第11期1233-1234,共2页Chinese Journal of Blood Transfusion

基　　金：国家高技术研究发展计划(863计划)(2013AA020201)

摘　　要：目的对上海血液生物有限公司提供的抗体筛选红细胞试剂在青海高原多民族地区的适宜性进行评估分析。方法对本院2011-2015年住院的61 601例患者不规则抗体筛查及相关抗体鉴定结果进行统计分析。结果61 601例不规则抗体筛查中检出不规则抗体阳性175例,经抗体谱细胞鉴定阳性174例,符合率99.4%。其中输血治疗21 943例,未发生因免疫抗体引起的溶血性输血不良反应。结论由上海血液生物有限公司提供的抗体筛选红细胞试剂能够达到本实验室在青海多民族地区就医人群的不规则抗体筛查要求。Objective To evaluate the suitability and performance of the antibody RBC screening reagents provided by Shanghai blood biological co.,LTD in the multi-race region of Qinghai plateau. Methods Statistical analysis was performed on 61601 patient records collected during Jan,2011-Dec,2015 regarding irregular antibody screening and correspondent antibody identification. Results 175 patients were confirmed positive among the 61601 patients in the irregular antibody screening test. 174 of which showed positive results in antibody spectrum cell identification,yielding a coincidence rate of99. 4 %. 21 943 of the patients were treated with blood transfusion,and no hemolytic transfusion reactions caused by immune antibody was recorded. Conclusion The antibody RBC screening reagents provided by Shanghai blood biological co.,LTD met the requirements of irregular antibody screening in the region according to the results generated in our lab.

关 键 词：青海高原 多民族 不规则抗体 试剂 适宜性 输血不良反应 

分 类 号：R457.11[医药卫生—治疗学]